News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3125last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Simply Wall St.122d agoneutral
Is Gilead Sciences (GILD) Cheap With Trodelvy And Yeztugo In Focus?Simply Wall St.122d agobullish
Gilead Sciences (GILD) Wins Trodelvy Approvals And Expands Texas CAR T AccessSimply Wall St.122d agobearish
Gilead Sciences (GILD) After Russell Growth Index Removal And A Fully Valued NarrativeInsider Monkey126d agobullish
Is Gilead (GILD) One of the Most Undervalued NASDAQ Stocks to Buy Right Now?Simply Wall St.135d agoneutral
Will Trodelvy’s First-Line TNBC Approval Redefine Gilead Sciences’ (GILD) Oncology-Led Investment Narrative?Simply Wall St.135d agobullish
Gilead Sciences (GILD) Wins First Line Trodelvy Approval In The US And EuropeInsider Monkey135d agoneutral
Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD) Following Positive HIV Trial ResultsThe Wall Street Journal137d agoneutral
New Drugs Are Replacing Chemo for Aggressive Breast CancerMarketBeat138d agoneutral
The Biotech Sector Looks Ready for a Multi-Year Breakout - Here's What to Watch.